Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingyi Gong

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
JACC. Heart Failure|July 28, 2022
Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With AnthracyclinesCarlos A Gongora, Zsofia D Drobni, Thiago Quinaglia Araujo Costa Silva, et al.
Immunotherapy Advances|September 20, 2021
Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitorsZsofia D Drobni, Sean P Murphy, Raza M Alvi, et al.
Circulation|October 2, 2020
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic PlaqueZsofia D Drobni, Raza M Alvi, Jana Taron, et al.
Cardiovascular Research|April 22, 2026
Inhibition of the PD-1 immune checkpoint and the development of heart failure in the presence of prior cardiac ischemiaTamás G Gergely, Zsófia D Drobni, Tamás Kovács, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
JACC. Heart Failure|July 28, 2022
Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With AnthracyclinesCarlos A Gongora, Zsofia D Drobni, Thiago Quinaglia Araujo Costa Silva, et al.
Immunotherapy Advances|September 20, 2021
Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitorsZsofia D Drobni, Sean P Murphy, Raza M Alvi, et al.
Circulation|October 2, 2020
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic PlaqueZsofia D Drobni, Raza M Alvi, Jana Taron, et al.
Cardiovascular Research|April 22, 2026
Inhibition of the PD-1 immune checkpoint and the development of heart failure in the presence of prior cardiac ischemiaTamás G Gergely, Zsófia D Drobni, Tamás Kovács, et al.
Pageof 5